<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04017169</url>
  </required_header>
  <id_info>
    <org_study_id>NORM PPCI</org_study_id>
    <nct_id>NCT04017169</nct_id>
  </id_info>
  <brief_title>No Reflow Phenomenon Incidence and Predictors</brief_title>
  <acronym>NORM-PPCI</acronym>
  <official_title>NO Reflow Phenomenon and Comparison to the Normal Flow Population Post Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hull University Teaching Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hull University Teaching Hospitals NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background No reflow phenomenon is described in up to 65% of patients undergoing primary&#xD;
      percutaneous coronary intervention for ST elevation myocardial infarction (STEMI). It is&#xD;
      known to be associated with worse outcomes but predictors of no reflow are not clearly&#xD;
      described.&#xD;
&#xD;
      Objectives A single centre case-control observational study of patients presenting with acute&#xD;
      myocardial infarction appropriate for PPCI comparing baseline clinical, biochemical and&#xD;
      angiographic characteristics between patients with no reflow phenomenon and those without.&#xD;
      Aiming to establish incidence for the UK population.&#xD;
&#xD;
      Secondary outcomes will be to gain further insight into those presenting with STEMI for PPCI&#xD;
      and develop a risk model to guide management and clinical outcomes of patients to 30days.&#xD;
&#xD;
      Methods This study will prospectively recruit all consecutive patients attending a single&#xD;
      centre for primary percutaneous coronary intervention for STEMI. Angiographic assessment of&#xD;
      the recanalised epicardial vessel will be used to diagnose no reflow (reduced TIMI flow or&#xD;
      blush grade). Baseline demographic, angiographic and biochemical characteristics and outcomes&#xD;
      at 30days for reflow and no reflow cohorts will be statistically assessed and compared with&#xD;
      logistic regression.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 29, 2015</start_date>
  <completion_date type="Actual">September 1, 2017</completion_date>
  <primary_completion_date type="Actual">May 31, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of no reflow phenomenon</measure>
    <time_frame>0-2 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predictors of no reflow phenomenon</measure>
    <time_frame>0-3 days</time_frame>
    <description>Statistical analysis of multiple variables to find independent predictors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE outcomes</measure>
    <time_frame>30 days</time_frame>
    <description>Cardiovascular death&#xD;
Death&#xD;
Hearth Failure (Killip class III/IV)&#xD;
MI&#xD;
CVA&#xD;
Repeat unplanned angiography&#xD;
Repeat unplanned revascularisation</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">176</enrollment>
  <condition>No Reflow Phenomenon</condition>
  <condition>STEMI</condition>
  <arm_group>
    <arm_group_label>No reflow phenomenon</arm_group_label>
    <description>Those that during procedure experience no reflow phenomenon&#xD;
To define no reflow requires:&#xD;
• Angiographic evidence of reopening of occluded coronary artery and successful stent placement with no evidence of flow-limiting residual stenosis (&lt;50%), dissection, vessel spasm, or thrombus burden&#xD;
and&#xD;
Angiographic documentation of a TIMI flow grade ≤II, or&#xD;
A TIMI flow grade III with a myocardial perfusion grade 0 or I, at least 10 min after the end of PCI procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No NRP</arm_group_label>
    <description>Normal angiographic coronary flow/blush post patent culprit vessel.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention as observational study</intervention_name>
    <arm_group_label>No NRP</arm_group_label>
    <arm_group_label>No reflow phenomenon</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The cohort is defined as all patients attending with ST elevation myocardial infarction&#xD;
        undergoing primary percutaneous coronary intervention. Cases are those subjects who&#xD;
        suffered no reflow phenomenon, with control comparators those that had TIMI III flow and&#xD;
        grade III myocardial blush post procedure.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Presenting with ST elevation myocardial infarction&#xD;
&#xD;
          -  Appropriate for Primary Percutaneous Coronary Intervention&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary Percutaneous Coronary Intervention not performed eg due to non- flow- limiting&#xD;
             coronary artery disease&#xD;
&#xD;
          -  Unsuccessful PCI&#xD;
&#xD;
          -  Thrombolysis&#xD;
&#xD;
          -  Patients who do not survive the procedure to leave the catheterisation laboratory&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer A Rossington, BSc MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hull University Teaching Hospitals NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Castle Hill Hospital (Hull and east Yorkshire Hospitals NHS Trust)</name>
      <address>
        <city>Cottingham</city>
        <state>East Yorkshire</state>
        <zip>HU16 5JQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 18, 2019</study_first_submitted>
  <study_first_submitted_qc>July 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2019</study_first_posted>
  <last_update_submitted>July 26, 2019</last_update_submitted>
  <last_update_submitted_qc>July 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>No-Reflow Phenomenon</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

